Likewise, the results of another study also showed that the loss of AKR1C1 is a good prognostic factor in patients with advanced NPC and increases the chemosensitivity of NPC cells to cisplatin [38]. Here, AKR1C1 is linked to nasopharyngeal carcinoma.